Figure 1.
Activation of AMPK by metformin and its principal downstream pathways involved in HF physiopathology. AMPK: AMP-dependent kinase; AT1R: AngII type 1 receptor; eNOS: endothelial nitric oxide synthase; eEF2: eukariotic elongation factor-2 kinase; GLUT4: glucose transporter protein type-4; JNK: c-Jun N-terminal kinase; NF-ĸB: nuclear factor-kB; OCT: organic cation transporter; p70S6K: protein kinase 70S6; PFK1: phosphofructokinase 1; PGC1α: peroxisome proliferator-activated receptor-g coactivator-1α; PKA: protein kinase A; SIRT1-2-3: deacetylase Sirtuin 1-2-3; TGF- β: transforming growth factor- β; TLR4: Toll-like receptor 4.
